Form 4 Filing for Imunon, Inc. - Officer and Director Stock Transaction

This filing details a stock transaction by Michael H. Tardugno, Executive Chairman of the Board at Imunon, Inc. On June 25, 2026, Tardugno acquired 42,519 shares of Common Stock at a price of $1.72 per share. This acquisition represents stock granted in lieu of cash for 50% of his 2025 annual bonus. Following this transaction, Tardugno directly owns 59,986 shares. Additionally, he indirectly owns 4,622 shares of Common Stock held within an IRA. The filing was signed by Susan Eylward, acting as attorney-in-fact for Michael Tardugno, on June 29, 2026.